Trial Profile
A Randomized, Double-blind, Active Drug Controlled, Multi-center, Phase Ⅰ/Ⅲ Study to Determine the Efficacy and Safety of Meditoxin in Treatment of Crow's Feet Line
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles
- Focus Registrational; Therapeutic Use
- Sponsors Medytox
- 01 Aug 2021 Results published in the Journal of Dermatological Treatment
- 13 Jul 2021 Primary endpoint (Percentage of Participants Achieving None or Mild on the Investigators Assessment of the Severity of Crows Feet Lines (CFL) at Maximum Smile Using the Facial Wrinkle Scale(FWS)) has been met as per results published in the Journal of Dermatological Treatment
- 25 Mar 2019 Status changed from recruiting to completed.